Contribution to the Personalized Healthcare for Melanoma Approval for BRAF inhibitor, “Zelboraf®” and its Companion Diagnostic, “cobas® 4800 BRAF V600 Mutation Test.”
Dec 26, 2014
Contribution to the Personalized Healthcare for Melanoma Approval for BRAF inhibitor, “Zelboraf®” and its Companion Diagnostic, “cobas® 4800 BRAF V600 Mutation Test.”
Contribution to the Personalized Healthcare for Melanoma Approval for BRAF inhibitor, “Zelboraf®” and its Companion Diagnostic, “cobas® 4800 BRAF V600 Mutation Test.”
